Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 51
  • Journal CiteScore: 46.50
  • Journal Impact Factor: 26.99
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Abstract

PHARMACOLOGICAL STUDY OF BIOTRANSFORMATION OF SUBSTITUTED AND UNSUBSTITUTED INDANONE ACETIC ACID ADDUCT WITH PYRAZOLONE RING FOR ANALGESIC ACTIVITY IN-VIVO

NIRALI A PASSI, MAULIK K PRAJAPATI, PROF DR DHRUBO JYOTI SEN AND PROF DR INDERMEET SINGH ANAND

Substituted and unsubstituted indanone acetic acids have been synthesized and conjugated with carboxy-pyrazolone to get indanonepyrazolone adduct. The antiinflammatory activity has been screened for Indanone acetic acid, Indanone-Pyrazolone adduct and Carboxy Pyrazolone by rat paw edema method with reference standard drug Indomethacin which is bioisosteres with indanone acetic acid ring. It has been observed that all the test compounds have anti-inflammatory activity and 70% inhibition of edema persists for 3 hours in the case of Indanone acetic acids and for Carboxy pyrazolone and 60-70% inhibition of edema persists for 5 hours in the case of Indanone-pyrazolone adduct. Indanone has non-heterocyclic fused ring having six membered benzene ring and five membered cyclopentane ring where as pyrazolone has five membered heterocyclic ring substituted with six membered benzene ring. The adduct of indanone acetic acid and carboxy pyrazolone joins with amide linkage which has free carboxy group which is present in the both Indanone acetic acid and Carboxy pyrazolone. Indanone-pyrazolone adduct shows high lipid solubility by partition coefficient rather than the other two compounds which shows the same % inhibition of edema and longer duration of analgesic activity which is equal to the other test compounds. It proves that the Indanone-Pyrazolone adduct shows activity for a certain period and then releases the two factors Indanone acetic acid and Carboxy Pyrazolone after hydrolysis of amide linkage by biotransformation in-vivo and the activity becomes prolonged but the % inhibition remains the same due to the in-vivo synergism appears and the combination activity of the three shows more prolonged action with longer duration by competitive inhibition of arachidonic acid pathway which has also free carboxylic acid group